| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.0009 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.087 | 0.004 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.096 | 0.004 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.082 | 0.004 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.004 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.094 | 0.004 |